Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Status unconfirmed · Phase 1

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase I trial to study the effectiveness of boron neuron capture therapy in treating patients with stage III melanoma.

Key facts

Study ID

NCT00002781

Run by

Beth Israel Deaconess Medical Center

People needed

15

Starts

1996-04-01

Last updated by the study team

2013-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Boston University School of Medicine — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.